When determining the costs of a valid, experimental evaluation of a new medical treatment, innovators often overlook the costs of
A) making a Type II error.
B) data collection.
C) monitoring the program and control groups participants.
D) not setting the probability of a Type I error accurately.

Question

Quizplus · Accepted Answer

Making a Type II error means failing to reject the null hypothesis when it is false. This can lead to the conclusion that the new treatment is not effective when it actually is. The costs of making a Type II error can include the cost of continuing to use the old treatment, which may be less effective or have more side effects.

When Determining the Costs of a Valid, Experimental Evaluation of a New